Problem statement: Answer the multiple-choice question.
Question: Which drug has a -0.200\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) COc1ccc(-n2ccc(=O)c(C(=O)O)n2)cc1
b.) COc1cccc(/C=N/NC(=O)c2ccoc2C)c1
c.) Cc1ccc(-c2ccc(SCC(=O)N3CCCc4ccccc43)nn2)cc1
Answer: c. Cc1ccc(-c2ccc(SCC(=O)N3CCCc4ccccc43)nn2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(-c2ccc(SCC(=O)N3CCCc4ccccc43)nn2)cc1
Cc1ccc(-c2ccc(SCC(=O)N3CCCc4ccccc43)nn2)cc1
1-(3,4-dihydro-2H-quinolin-1-yl)-2-[6-(4-methylphenyl)pyridazin-3-yl]sulfanylethanone